JAZZ downtrend intactWe can observe how the price continues to decline within the descending channel. Current pullback might present a solid RR selling opportunity.
JAZZ trade ideas
Jazz Pharmaceuticals: High Life 🍁It must be 420 somewhere, since the Jazz Pharmaceuticals stock is paving its way higher and higher to ultimately reach the orange target zone. Once the blue wave (b) is completed, the stock should drop all the way below the $125.36 support line and continue the correction until the end of the green wave within the yellow trading area. Once the course has hit the corrective low, it can turn back up and start a sturdy upwards trend.
JAZZ PHARMACEUTICALS Estimates DailyHey my friends, JAZZ PHARMACEUTICALS is in a bullish movement with a rising leg doji and low sell volume traded. In the TIMEFRAME M1 we notice a large hammer candle with a low return on purchase volume. She goes on the VWAP to test it as well as the bollinger's bollinger and ends up on the top of the stabilization zone to check it. Strong possibility of breaking the price with the return of momentum for both the area to go in a second and land in a next high. Before a next breakout a stabilization zone (on the TIMEFRAME H4) come on the last trade see if the excess is giving way with bearish breakout gap filling. And some resistance to pass (on the TIMEFRAME H1) we can see a conviction to come and fill the same.
Please LIKE & FOLLOW, thank you!
Cup and HandleFell from a rising wedge and off JAZZ went.
This one looked bearish for a while but is looking much better.
Cup low is 86.88 cup high is 154.24 Breakout is 154.34 ( a bit over cup high. Cup depth is 67.36
Mid cup is 129.56. Handle low is 139.6 Support is found here and last pivot low.
Targets are calculated using cup deth and fib levels and added to cup break out. Cup high and not break out level is used to calculate cup depth. I use 38, 61, 79, sometimes 100 % for targets 1. In a bullish market folks add 127 and 161 percent to cup breakout level
Not a recommendation
Cup and HandleJAZZ fell from a rising wedge that was narrowing but has perhaps fell as far as it will fall..
RW (rising wedges that narrow at apex) are almost always bearish ..it is often a long term pattern and not valid unless bottom trendline is broken..
OBV and NV are both high..short percent a bit higher than I like..
Do your research on this one if you like the stock..
Support at handle low (HL) and mid cup (MC)..I see strong S at 139.5ish
C&H patterns are common patterns and like any other pattern they can fail...Targets are calculated using the depth of the cup..the handle low is an area on congestion that can be support..
Not a recommendation
Cup and HandleThere is also a Narrowing Rising Wedge in this chart
A rising wedge can be a very long term pattern that is caused by too much buying without healthy pull backs. "Irrational Exuberance"
In the end, there is a shortage of buyers and if the pattern breaks the bottom trendline, the pattern is valid. It is not valid until then
Shorties (Those who go short) love this pattern as it once the stock breaks that bottom trendline, fate takes over. The short is increasing on this one.
Often the RW causes issues during a pull back due to limited buyers left, but I have also noticed it happens at earnings as well. The company will beat, yet a deep pull back ensues despite the earnings beat
I do not go short, but I do respect their opinion and the reason I look at short interest is to find sentiment on the stock.
A RW can fall a very short way, or just have a candle tail dip out and be done, or it can fall to the angle of where the RW started. IE, draw a straight line from bottom line of RW. I drew a small orane line to demonstrate how far JAZZ could fall. There is a gap above this though that would probably provide support. Seldom does a strong stock fall this far, but an example is HRC which can be found in my posts with a demo of the complete fall from a RW
I am not saying JAZZ will fall much at all. Just saying keep your eye on bottom trendline of RW (O:
Negative volume (NV) is high on this one showing there is still large player interest as they buy on down days
There is also a gap below price but looks like it has been filled
I am choosing long on this one with caution encouraged
Not a recommendation
Be safe
Jazz Pharmaceuticals Announces Positive Top-line Results from PhJAZZ: Jazz Pharmaceuticals plc
2020-10-08 07:30:00
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia
JAZZ/USD Long$JAZZ looks to be in bullish continuation here:
On the 1D chart it looks like it wants to visit
$143/144
(potentially after a retest of the diagonal it
broke out from around $125)
Reasons:
-It had a strong breakout from a bullish pennant,
the target for this breakout would be the height
of the bull pennant's flagpole added to the point
where price broke out of the pennant
-Price may like to visit near the top diagonal of
the multi-year trend channel, adding conviction
to the target of the bull pennant
Bullish bias continued via Ichimoku:
-Kumo cloud is green
-Tenkan is above the Kijun while both
are above the kumo cloud
-Lagging span is well above the kumo cloud
Other Indicators:
-MACD seems to have just flipped bullish
-RSI not yet in overbought territory
-(not included in chart) price is not yet above
the top MA of the Bollinger Bands so still some
room for price to expand to target
Gap to be filled (in time) at $112.45
$JAZZ Upside Targets Insider buying details
Mulligan Seamus Director May 27 Buy 111.26 35,000 3,894,058 1,152,788 May 27 06:36 PM
Mulligan Seamus Director May 26 Buy 110.65 15,000 1,659,747 1,117,788 May 27 06:36 PM
Jazz Pharmaceuticals Announces Positive Top-line Results JAZZ: Jazz Pharmaceuticals plc
2019-03-26 16:13:00
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness - PR Newswire
Jazz Pharmaceuticals Announces Share Repurchase Program AuthorizJAZZ: Jazz Pharmaceuticals plc
2018-12-10 16:10:00
Jazz Pharmaceuticals Announces Share Repurchase Program Authorization Increase of $400 Million
Jazz long!!Good trading week. I have not closed any position yet as you guys know i don't trade lower time frames. Some good opportunities came this week. Let's take a look at jazz which i bought today.
Monthly is nice chart with kijun sen holding firmly. Macd is above zero but trying to cross up but won't be confirmed till the end of the month.
Weekly is again bullish with macd crossed up and kijun sen holding. Price is flirting with a trendline . Chikou need to get out of price for acceleration.
Daily is bullish with bullish candle today with macd pointing higher.
There is also inverted monthly head and shoulder with measured move to 220. Very nice rr here.
This trade meet all my criteria and i initiated a long . Let's see how this one plays out.
Thanks for the read. I just finished journalling this one and now it's time to get some wine.
Cheers
this is a nice buying area for this stockI hope this will happen so you can buy this stock in this area
Looking To Go Long $JAZZJAZZ completing a falling wedge pattern with a bullish RSI Divergence. Falling into support area with volume profile and trend support. Keep an eye on this one.
JAZZ looks ready to go longAs the entire Pharma sector seems to be moving higher, JAZZ appears ready to join in. Finding support at the 75sma it is now moving away from it higher. Watch the double top, a break above that would be bullish. IMHO
JAZZ: Go LongJAZZ has completed a textbook A-B-C correction bottoming out at 95.80 in Nov 2016.
Sharp reversal at 50% fib retracement is good sign.
2W RSI and MACD divergence is a significant supporting evidence of the upturn.
Look for an initial target of its previous high of 194.
Critical support at Minuette Wave C at 95.80.
Break of this low will invalidate the trade.
JAZZ Long-term Trend ContinuationStrong channel downtrend since Aug 2015, with RSI overbought at ideal short entry levels (small green squares). RSI at overbought level again; signal to short in this case with harmonic period of about 6 months.
Also current small double top at about $130 mark (short orange); stock expected to close gap to about $118 for initial target short-term target. That same level may be difficult to break; level is previous significant support level, so price may consolidate around $118 before breakdown to ideal target (large green rectangle).
Initial Target @ $118
Ideal Target @ 95-85
Stock has a lot of room to fall so it can break $85 when it gets there; needs time to work. High profit potential play.
